Stifel lowered the firm’s price target on Adient (ADNT) to $26 from $30 and keeps a Buy rating on the shares. The firm thinks Q1 earnings season is likely to “provide few surprises or guidance changes to act as catalysts” for its flow control and multi-industry coverage, the analyst tells investors in a preview for the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT: